Description

This issue of Vital Signs, released on March 17, 2008, provides an strategic overview of changes in mammography imaging practices. Additionally, a company spotlight is provided for Dexela Ltd., a developer of novel 3-D technologies that enhance the quality and accuracy of breast cancer screening. Reimbursement and regulatory news from the FDA is also provided for the week of March 2 - March 6, 2008.